Patents Assigned to Vitalis Analgesics LLC
  • Oral administration of ketamine
    Patent number: 11382873
    Abstract: Disclosed are pharmaceutical compositions having a portion of ketamine for intraoral release and another ketamine for gastrointestinal release. The compositions can further include aspirin. The disclosed formulations and related administration approaches improve the bioavailability and efficacy of oral ketamine.
    Type: Grant
    Filed: August 25, 2021
    Date of Patent: July 12, 2022
    Assignee: Vitalis Analgesics LLC
    Inventor: Joseph Habboushe